FDA Adverse Event Death Summary report: N

LIFEVEST WCD 4000 SYSTEM

MDR report key: 3924766 · Received June 30, 2014

Report

Report Number
3008642652-2014-01991
Event Type
Death
Date Received
June 30, 2014
Date of Event
June 1, 2014
Report Date
June 26, 2014
Manufacturer
ZOLL MANUFACTURING CORPORATION
Product Code
MVK
PMA / PMN Number
P010030
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION SUMMARY. DEVICE EVALUATION OF BELT SN (B)(4) IS COMPLETE. AS RECEIVED THE BELT WAS ABLE TO DETECT AND TREAT. DEVICE EVALUATION OF MONITOR SN (B)(4) HAS NOT YET BEEN COMPLETED. THERE IS NO EVIDENCE AVAILABLE AT THIS TIME TO SUGGEST THE DEVICE WAS UNABLE TO DETECT AND TREAT WHILE IN USE. A SUPPLEMENTAL REPORT WILL BE SENT IF A DEFICIENCY IS IDENTIFIED UPON EVALUATION. VENTRICULAR TACHYCARDIA (VT) AT 136 BPM WAS DETECTED AT 05:05:38 ON (B)(4) 2014. THE LIFEVEST DELIVERED AN APPROPRIATE TREATMENT IN RESPONSE TO THE ARRHYTHMIA AT 04:06:16 WITH A POST SHOCK RHYTHM OF VT AT 122 BPM. THE LIFEVEST DELIVERED TWO OTHER TREATMENTS IN RESPONSE TO CPR ARTIFACT. THE POST SHOCK RHYTHMS WERE CPR ARTIFACT WITH PERIODS OF ASYSTOLE AND SEVERE BRADYCARDIA RESPECTIVELY. THE PATIENT PASSED AWAY AROUND 4:30:00 ON (B)(6) 2014 WHILE IN THE HOSPITAL. THE PATIENT WAS WEARING THE DEVICE AT TIME OF DEATH. REVIEW OF THE PATIENT'S FLAGS AND ECG STRIPS SUGGESTS THAT THE LIFEVEST WAS ABLE TO DETECT AND TREAT WHILE IN USE. NO DEFICIENCIES WERE ALLEGED AGAINST THE DEVICE.

Description of Event or Problem · 1

ZOLL LOGISTICS CONTACTED ZOLL CUSTOMER SUPPORT ON (B)(4) 2014 TO REPORT THAT A (B)(6) YEAR OLD MALE PATIENT PASSED AWAY AT THE HOSPITAL ON (B)(6) 2014. PRIOR TO PASSING, THE PATIENT RECEIVED THREE TREATMENT SHOCKS. NO DEFICIENCIES WERE ALLEGED AGAINST THE EQUIPMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
378670 LIFEVEST WCD 4000 SYSTEM WEARABLE CARDIOVERTER DEFIBRILLATOR MVK ZOLL MANUFACTURING CORPORATION WCD 4000 NA

Patients

Seq Age Sex Outcome Treatment
1 78 YR Death